Glaucoma 360: Fostering innovation in the face of costs, policy issues
February 8th 2020Delivering the Drs. Henry and Frederick Sutro Memorial Lecture, David W. Parke II, MD, CEO of the American Academy of Ophthalmology, points out that patients and physicians can benefit from innovations in treatment. However, health policy and economics often can stand in the way of innovation.
Read More
Contact lens drug delivery for glaucoma: A better way to get there
February 7th 2020At Glaucoma 360, Diopter Corp. CEO Chris Adams discussed a contact lens device that has been found effective for treating glaucoma because it was engineered with vitamin E nano-barriers to extend drug release.
Read More